+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Montelukast Sodium Market 2026-2030

  • PDF Icon

    Report

  • 294 Pages
  • May 2026
  • Region: Global
  • TechNavio
  • ID: 5601903
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global montelukast sodium market is forecasted to grow by USD 1.49 billion during 2025-2030, accelerating at a CAGR of 4.6% during the forecast period. The report on the global montelukast sodium market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating prevalence of chronic respiratory diseases and allergic rhinitis increasing market demand, increase in patient awareness, strong pipeline and new drug approvals.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The global montelukast sodium market is segmented as below:

By Type

  • Tablets
  • Chewable tablets
  • Oral solutions

By Distribution Channel

  • Retail pharmacies
  • Hospital pharmacies
  • Online pharmacies

By Application

  • Asthma
  • Allergic rhinitis
  • Others

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Asia
  • Rest of World (RoW)
  • Rest of World (RoW)
This study identifies the innovations in drug delivery systems and rise of fixed dose combination therapies as one of the prime reasons driving the global montelukast sodium market growth during the next few years. Also, increase in collaborations and expanding research in curative approaches will lead to sizable demand in the market.

The report on the global montelukast sodium market covers the following areas:

  • Global montelukast sodium market sizing
  • Global montelukast sodium market forecast
  • Global montelukast sodium market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global montelukast sodium market vendors that include Aarti Pharmalabs Ltd., Amneal Pharmaceuticals Inc., Apotex Inc., Aurobindo Pharma Ltd., Cipla Inc., Dr. Reddys Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Hetero Labs Ltd., Inke S.A., Jubilant Pharmova Ltd., Lupin Ltd., Macleods Pharmaceuticals Ltd., Merck KGaA, Metrochem API Pvt. Ltd., Morepen Laboratories Ltd., Sun Pharmaceutical Industries, Teva Pharmaceutical Ltd., Torrent Pharmaceuticals Ltd., Viatris Inc. Also, the global montelukast sodium market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
  • Chart on Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
  • Chart on Overview on factors of disruption
2.4 Impact of drivers and challenges
  • Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
  • Chart on Parent Market
  • Data Table on - Parent Market
3.2 Market characteristics
  • Chart on Market characteristics analysis
3.3 Value chain analysis
  • Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
  • Data Table on Offerings of companies included in the market definition
4.2 Market segment analysis
  • Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030
  • Chart on Global - Market size and forecast 2025-2030 ($ million)
  • Data Table on Global - Market size and forecast 2025-2030 ($ million)
  • Chart on Global Market: Year-over-year growth 2025-2030 (%)
  • Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Montelukast Sodium Market 2020 - 2024
  • Historic Market Size - Data Table on Global Montelukast Sodium Market 2020 - 2024 ($ million)
5.2 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
5.3 Distribution Channel segment analysis 2020 - 2024
  • Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
5.4 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on Global Montelukast Sodium Market
6.2 Impact of Geopolitical Conflicts on Global Montelukast Sodium Market
7 Five Forces Analysis
7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition
  • Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Type
8.1 Market segments
  • Chart on Type - Market share 2025-2030 (%)
  • Data Table on Type - Market share 2025-2030 (%)
8.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
8.3 Tablets - Market size and forecast 2025-2030
  • Chart on Tablets - Market size and forecast 2025-2030 ($ million)
  • Data Table on Tablets - Market size and forecast 2025-2030 ($ million)
  • Chart on Tablets - Year-over-year growth 2025-2030 (%)
  • Data Table on Tablets - Year-over-year growth 2025-2030 (%)
8.4 Chewable tablets - Market size and forecast 2025-2030
  • Chart on Chewable tablets - Market size and forecast 2025-2030 ($ million)
  • Data Table on Chewable tablets - Market size and forecast 2025-2030 ($ million)
  • Chart on Chewable tablets - Year-over-year growth 2025-2030 (%)
  • Data Table on Chewable tablets - Year-over-year growth 2025-2030 (%)
8.5 Oral solutions - Market size and forecast 2025-2030
  • Chart on Oral solutions - Market size and forecast 2025-2030 ($ million)
  • Data Table on Oral solutions - Market size and forecast 2025-2030 ($ million)
  • Chart on Oral solutions - Year-over-year growth 2025-2030 (%)
  • Data Table on Oral solutions - Year-over-year growth 2025-2030 (%)
8.6 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Distribution Channel
9.1 Market segments
  • Chart on Distribution Channel - Market share 2025-2030 (%)
  • Data Table on Distribution Channel - Market share 2025-2030 (%)
9.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
9.3 Retail pharmacies - Market size and forecast 2025-2030
  • Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
  • Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
  • Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
  • Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
9.4 Hospital pharmacies - Market size and forecast 2025-2030
  • Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
  • Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
  • Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
  • Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
9.5 Online pharmacies - Market size and forecast 2025-2030
  • Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
  • Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
  • Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
  • Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
9.6 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)
  • Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Application
10.1 Market segments
  • Chart on Application - Market share 2025-2030 (%)
  • Data Table on Application - Market share 2025-2030 (%)
10.2 Comparison by Application
  • Chart on Comparison by Application
  • Data Table on Comparison by Application
10.3 Asthma - Market size and forecast 2025-2030
  • Chart on Asthma - Market size and forecast 2025-2030 ($ million)
  • Data Table on Asthma - Market size and forecast 2025-2030 ($ million)
  • Chart on Asthma - Year-over-year growth 2025-2030 (%)
  • Data Table on Asthma - Year-over-year growth 2025-2030 (%)
10.4 Allergic rhinitis - Market size and forecast 2025-2030
  • Chart on Allergic rhinitis - Market size and forecast 2025-2030 ($ million)
  • Data Table on Allergic rhinitis - Market size and forecast 2025-2030 ($ million)
  • Chart on Allergic rhinitis - Year-over-year growth 2025-2030 (%)
  • Data Table on Allergic rhinitis - Year-over-year growth 2025-2030 (%)
10.5 Others - Market size and forecast 2025-2030
  • Chart on Others - Market size and forecast 2025-2030 ($ million)
  • Data Table on Others - Market size and forecast 2025-2030 ($ million)
  • Chart on Others - Year-over-year growth 2025-2030 (%)
  • Data Table on Others - Year-over-year growth 2025-2030 (%)
10.6 Market opportunity by Application
  • Market opportunity by Application ($ million)
  • Data Table on Market opportunity by Application ($ million)
11 Customer Landscape
11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
  • Chart on Market share by geography 2025-2030 (%)
  • Data Table on Market share by geography 2025-2030 (%)
12.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
12.3 North America - Market size and forecast 2025-2030
  • Chart on North America - Market size and forecast 2025-2030 ($ million)
  • Data Table on North America - Market size and forecast 2025-2030 ($ million)
  • Chart on North America - Year-over-year growth 2025-2030 (%)
  • Data Table on North America - Year-over-year growth 2025-2030 (%)
  • Chart on Regional Comparison - North America
  • Data Table on Regional Comparison - North America
12.3.1 US - Market size and forecast 2025-2030
  • Chart on US - Market size and forecast 2025-2030 ($ million)
  • Data Table on US - Market size and forecast 2025-2030 ($ million)
  • Chart on US - Year-over-year growth 2025-2030 (%)
  • Data Table on US - Year-over-year growth 2025-2030 (%)
12.3.2 Canada - Market size and forecast 2025-2030
  • Chart on Canada - Market size and forecast 2025-2030 ($ million)
  • Data Table on Canada - Market size and forecast 2025-2030 ($ million)
  • Chart on Canada - Year-over-year growth 2025-2030 (%)
  • Data Table on Canada - Year-over-year growth 2025-2030 (%)
12.3.3 Mexico - Market size and forecast 2025-2030
  • Chart on Mexico - Market size and forecast 2025-2030 ($ million)
  • Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
  • Chart on Mexico - Year-over-year growth 2025-2030 (%)
  • Data Table on Mexico - Year-over-year growth 2025-2030 (%)
12.4 Europe - Market size and forecast 2025-2030
  • Chart on Europe - Market size and forecast 2025-2030 ($ million)
  • Data Table on Europe - Market size and forecast 2025-2030 ($ million)
  • Chart on Europe - Year-over-year growth 2025-2030 (%)
  • Data Table on Europe - Year-over-year growth 2025-2030 (%)
  • Chart on Regional Comparison - Europe
  • Data Table on Regional Comparison - Europe
12.4.1 Germany - Market size and forecast 2025-2030
  • Chart on Germany - Market size and forecast 2025-2030 ($ million)
  • Data Table on Germany - Market size and forecast 2025-2030 ($ million)
  • Chart on Germany - Year-over-year growth 2025-2030 (%)
  • Data Table on Germany - Year-over-year growth 2025-2030 (%)
12.4.2 UK - Market size and forecast 2025-2030
  • Chart on UK - Market size and forecast 2025-2030 ($ million)
  • Data Table on UK - Market size and forecast 2025-2030 ($ million)
  • Chart on UK - Year-over-year growth 2025-2030 (%)
  • Data Table on UK - Year-over-year growth 2025-2030 (%)
12.4.3 France - Market size and forecast 2025-2030
  • Chart on France - Market size and forecast 2025-2030 ($ million)
  • Data Table on France - Market size and forecast 2025-2030 ($ million)
  • Chart on France - Year-over-year growth 2025-2030 (%)
  • Data Table on France - Year-over-year growth 2025-2030 (%)
12.4.4 Italy - Market size and forecast 2025-2030
  • Chart on Italy - Market size and forecast 2025-2030 ($ million)
  • Data Table on Italy - Market size and forecast 2025-2030 ($ million)
  • Chart on Italy - Year-over-year growth 2025-2030 (%)
  • Data Table on Italy - Year-over-year growth 2025-2030 (%)
12.4.5 Spain - Market size and forecast 2025-2030
  • Chart on Spain - Market size and forecast 2025-2030 ($ million)
  • Data Table on Spain - Market size and forecast 2025-2030 ($ million)
  • Chart on Spain - Year-over-year growth 2025-2030 (%)
  • Data Table on Spain - Year-over-year growth 2025-2030 (%)
12.4.6 The Netherlands - Market size and forecast 2025-2030
  • Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
  • Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
  • Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
  • Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
12.5 Asia - Market size and forecast 2025-2030
  • Chart on Asia - Market size and forecast 2025-2030 ($ million)
  • Data Table on Asia - Market size and forecast 2025-2030 ($ million)
  • Chart on Asia - Year-over-year growth 2025-2030 (%)
  • Data Table on Asia - Year-over-year growth 2025-2030 (%)
  • Chart on Regional Comparison - Asia
  • Data Table on Regional Comparison - Asia
12.5.1 China - Market size and forecast 2025-2030
  • Chart on China - Market size and forecast 2025-2030 ($ million)
  • Data Table on China - Market size and forecast 2025-2030 ($ million)
  • Chart on China - Year-over-year growth 2025-2030 (%)
  • Data Table on China - Year-over-year growth 2025-2030 (%)
12.5.2 Japan - Market size and forecast 2025-2030
  • Chart on Japan - Market size and forecast 2025-2030 ($ million)
  • Data Table on Japan - Market size and forecast 2025-2030 ($ million)
  • Chart on Japan - Year-over-year growth 2025-2030 (%)
  • Data Table on Japan - Year-over-year growth 2025-2030 (%)
12.5.3 India - Market size and forecast 2025-2030
  • Chart on India - Market size and forecast 2025-2030 ($ million)
  • Data Table on India - Market size and forecast 2025-2030 ($ million)
  • Chart on India - Year-over-year growth 2025-2030 (%)
  • Data Table on India - Year-over-year growth 2025-2030 (%)
12.5.4 South Korea - Market size and forecast 2025-2030
  • Chart on South Korea - Market size and forecast 2025-2030 ($ million)
  • Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
  • Chart on South Korea - Year-over-year growth 2025-2030 (%)
  • Data Table on South Korea - Year-over-year growth 2025-2030 (%)
12.5.5 Thailand - Market size and forecast 2025-2030
  • Chart on Thailand - Market size and forecast 2025-2030 ($ million)
  • Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
  • Chart on Thailand - Year-over-year growth 2025-2030 (%)
  • Data Table on Thailand - Year-over-year growth 2025-2030 (%)
12.5.6 Indonesia - Market size and forecast 2025-2030
  • Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
  • Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
  • Chart on Indonesia - Year-over-year growth 2025-2030 (%)
  • Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
  • Chart on Regional Comparison - Rest of World (ROW)
  • Data Table on Regional Comparison - Rest of World (ROW)
12.6.1 Brazil - Market size and forecast 2025-2030
  • Chart on Brazil - Market size and forecast 2025-2030 ($ million)
  • Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
  • Chart on Brazil - Year-over-year growth 2025-2030 (%)
  • Data Table on Brazil - Year-over-year growth 2025-2030 (%)
12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
  • Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
  • Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
  • Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
12.6.3 UAE - Market size and forecast 2025-2030
  • Chart on UAE - Market size and forecast 2025-2030 ($ million)
  • Data Table on UAE - Market size and forecast 2025-2030 ($ million)
  • Chart on UAE - Year-over-year growth 2025-2030 (%)
  • Data Table on UAE - Year-over-year growth 2025-2030 (%)
12.6.4 South Africa - Market size and forecast 2025-2030
  • Chart on South Africa - Market size and forecast 2025-2030 ($ million)
  • Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
  • Chart on South Africa - Year-over-year growth 2025-2030 (%)
  • Data Table on South Africa - Year-over-year growth 2025-2030 (%)
12.6.5 Turkey - Market size and forecast 2025-2030
  • Chart on Turkey - Market size and forecast 2025-2030 ($ million)
  • Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
  • Chart on Turkey - Year-over-year growth 2025-2030 (%)
  • Data Table on Turkey - Year-over-year growth 2025-2030 (%)
12.6.6 Argentina - Market size and forecast 2025-2030
  • Chart on Argentina - Market size and forecast 2025-2030 ($ million)
  • Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
  • Chart on Argentina - Year-over-year growth 2025-2030 (%)
  • Data Table on Argentina - Year-over-year growth 2025-2030 (%)
12.6.7 Colombia - Market size and forecast 2025-2030
  • Chart on Colombia - Market size and forecast 2025-2030 ($ million)
  • Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
  • Chart on Colombia - Year-over-year growth 2025-2030 (%)
  • Data Table on Colombia - Year-over-year growth 2025-2030 (%)
12.6.8 Israel - Market size and forecast 2025-2030
  • Chart on Israel - Market size and forecast 2025-2030 ($ million)
  • Data Table on Israel - Market size and forecast 2025-2030 ($ million)
  • Chart on Israel - Year-over-year growth 2025-2030 (%)
  • Data Table on Israel - Year-over-year growth 2025-2030 (%)
12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
  • Escalating prevalence of chronic respiratory diseases and allergic rhinitis increasing market demand
  • Increase in patient awareness
  • Strong pipeline and new drug approvals
13.2 Market challenges
  • Regulatory stringency and neuropsychiatric safety mandates
  • Increased use of complementary and alternative medicine
  • High cost of conducting clinical trials
13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
13.4 Market opportunities
  • Innovations in drug delivery systems and rise of fixed dose combination therapies
  • Increase in collaborations
  • Expanding research in curative approaches
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
  • Overview on factors of disruption
14.4 Industry risks
  • Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
  • Companies covered
15.2 Company ranking index
  • Company ranking index
15.3 Market positioning of companies
  • Matrix on companies position and classification
15.4 Aarti Pharmalabs Ltd.
  • Aarti Pharmalabs Ltd. - Overview
  • Aarti Pharmalabs Ltd. - Business segments
  • Aarti Pharmalabs Ltd. - Key offerings
  • Aarti Pharmalabs Ltd. - Segment focus
  • SWOT
15.5 Amneal Pharmaceuticals Inc.
  • Amneal Pharmaceuticals Inc. - Overview
  • Amneal Pharmaceuticals Inc. - Business segments
  • Amneal Pharmaceuticals Inc. - Key news
  • Amneal Pharmaceuticals Inc. - Key offerings
  • Amneal Pharmaceuticals Inc. - Segment focus
  • SWOT
15.6 Apotex Inc.
  • Apotex Inc. - Overview
  • Apotex Inc. - Product / Service
  • Apotex Inc. - Key offerings
  • SWOT
15.7 Aurobindo Pharma Ltd.
  • Aurobindo Pharma Ltd. - Overview
  • Aurobindo Pharma Ltd. - Business segments
  • Aurobindo Pharma Ltd. - Key news
  • Aurobindo Pharma Ltd. - Key offerings
  • Aurobindo Pharma Ltd. - Segment focus
  • SWOT
15.8 Cipla Inc.
  • Cipla Inc. - Overview
  • Cipla Inc. - Business segments
  • Cipla Inc. - Key news
  • Cipla Inc. - Key offerings
  • Cipla Inc. - Segment focus
  • SWOT
15.9 Dr. Reddys Laboratories Ltd.
  • Dr. Reddys Laboratories Ltd. - Overview
  • Dr. Reddys Laboratories Ltd. - Business segments
  • Dr. Reddys Laboratories Ltd. - Key news
  • Dr. Reddys Laboratories Ltd. - Key offerings
  • Dr. Reddys Laboratories Ltd. - Segment focus
  • SWOT
15.10 Glenmark Pharmaceuticals Ltd.
  • Glenmark Pharmaceuticals Ltd. - Overview
  • Glenmark Pharmaceuticals Ltd. - Product / Service
  • Glenmark Pharmaceuticals Ltd. - Key news
  • Glenmark Pharmaceuticals Ltd. - Key offerings
  • SWOT
15.11 Jubilant Pharmova Ltd.
  • Jubilant Pharmova Ltd. - Overview
  • Jubilant Pharmova Ltd. - Business segments
  • Jubilant Pharmova Ltd. - Key offerings
  • Jubilant Pharmova Ltd. - Segment focus
  • SWOT
15.12 Lupin Ltd.
  • Lupin Ltd. - Overview
  • Lupin Ltd. - Business segments
  • Lupin Ltd. - Key news
  • Lupin Ltd. - Key offerings
  • Lupin Ltd. - Segment focus
  • SWOT
15.13 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
  • SWOT
15.14 Morepen Laboratories Ltd.
  • Morepen Laboratories Ltd. - Overview
  • Morepen Laboratories Ltd. - Business segments
  • Morepen Laboratories Ltd. - Key offerings
  • Morepen Laboratories Ltd. - Segment focus
  • SWOT
15.15 Sun Pharmaceutical Industries
  • Sun Pharmaceutical Industries - Overview
  • Sun Pharmaceutical Industries - Business segments
  • Sun Pharmaceutical Industries - Key news
  • Sun Pharmaceutical Industries - Key offerings
  • Sun Pharmaceutical Industries - Segment focus
  • SWOT
15.16 Teva Pharmaceutical Ltd.
  • Teva Pharmaceutical Ltd. - Overview
  • Teva Pharmaceutical Ltd. - Business segments
  • Teva Pharmaceutical Ltd. - Key news
  • Teva Pharmaceutical Ltd. - Key offerings
  • Teva Pharmaceutical Ltd. - Segment focus
  • SWOT
15.17 Torrent Pharmaceuticals Ltd.
  • Torrent Pharmaceuticals Ltd. - Overview
  • Torrent Pharmaceuticals Ltd. - Product / Service
  • Torrent Pharmaceuticals Ltd. - Key offerings
  • SWOT
15.18 Viatris Inc.
  • Viatris Inc. - Overview
  • Viatris Inc. - Business segments
  • Viatris Inc. - Key news
  • Viatris Inc. - Key offerings
  • Viatris Inc. - Segment focus
  • SWOT
16 Appendix
16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
16.4 Research methodology
  • Research methodology
16.5 Data procurement
  • Information sources
16.6 Data validation
  • Data validation
16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
16.8 Data synthesis
  • Data synthesis
16.9 360 degree market analysis
  • 360 degree market analysis
16.10 List of abbreviations
  • List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 7: Executive Summary - Chart on Market Segmentation by Application
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Montelukast Sodium Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Type - Market share 2025-2030 (%)
Exhibit 39: Data Table on Type - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Type
Exhibit 41: Data Table on Comparison by Type
Exhibit 42: Chart on Tablets - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Tablets - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Tablets - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Tablets - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Chewable tablets - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Chewable tablets - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Chewable tablets - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Chewable tablets - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Oral solutions - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Oral solutions - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Oral solutions - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Oral solutions - Year-over-year growth 2025-2030 (%)
Exhibit 54: Market opportunity by Type ($ million)
Exhibit 55: Data Table on Market opportunity by Type ($ million)
Exhibit 56: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 57: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 58: Chart on Comparison by Distribution Channel
Exhibit 59: Data Table on Comparison by Distribution Channel
Exhibit 60: Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 72: Market opportunity by Distribution Channel ($ million)
Exhibit 73: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 74: Chart on Application - Market share 2025-2030 (%)
Exhibit 75: Data Table on Application - Market share 2025-2030 (%)
Exhibit 76: Chart on Comparison by Application
Exhibit 77: Data Table on Comparison by Application
Exhibit 78: Chart on Asthma - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Asthma - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Asthma - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Asthma - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on Allergic rhinitis - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Allergic rhinitis - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Allergic rhinitis - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Allergic rhinitis - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 90: Market opportunity by Application ($ million)
Exhibit 91: Data Table on Market opportunity by Application ($ million)
Exhibit 92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 93: Chart on Market share by geography 2025-2030 (%)
Exhibit 94: Data Table on Market share by geography 2025-2030 (%)
Exhibit 95: Chart on Geographic comparison
Exhibit 96: Data Table on Geographic comparison
Exhibit 97: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 98: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 99: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 100: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 101: Chart on Regional Comparison - North America
Exhibit 102: Data Table on Regional Comparison - North America
Exhibit 103: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Regional Comparison - Europe
Exhibit 120: Data Table on Regional Comparison - Europe
Exhibit 121: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 122: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Regional Comparison - Asia
Exhibit 150: Data Table on Regional Comparison - Asia
Exhibit 151: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 180: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 181: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 213: Market opportunity by geography ($ million)
Exhibit 214: Data Tables on Market opportunity by geography ($ million)
Exhibit 215: Impact of drivers and challenges in 2025 and 2030
Exhibit 216: Overview on criticality of inputs and factors of differentiation
Exhibit 217: Overview on factors of disruption
Exhibit 218: Impact of key risks on business
Exhibit 219: Companies covered
Exhibit 220: Company ranking index
Exhibit 221: Matrix on companies position and classification
Exhibit 222: Aarti Pharmalabs Ltd. - Overview
Exhibit 223: Aarti Pharmalabs Ltd. - Business segments
Exhibit 224: Aarti Pharmalabs Ltd. - Key offerings
Exhibit 225: Aarti Pharmalabs Ltd. - Segment focus
Exhibit 226: SWOT
Exhibit 227: Amneal Pharmaceuticals Inc. - Overview
Exhibit 228: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 229: Amneal Pharmaceuticals Inc. - Key news
Exhibit 230: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 231: Amneal Pharmaceuticals Inc. - Segment focus
Exhibit 232: SWOT
Exhibit 233: Apotex Inc. - Overview
Exhibit 234: Apotex Inc. - Product / Service
Exhibit 235: Apotex Inc. - Key offerings
Exhibit 236: SWOT
Exhibit 237: Aurobindo Pharma Ltd. - Overview
Exhibit 238: Aurobindo Pharma Ltd. - Business segments
Exhibit 239: Aurobindo Pharma Ltd. - Key news
Exhibit 240: Aurobindo Pharma Ltd. - Key offerings
Exhibit 241: Aurobindo Pharma Ltd. - Segment focus
Exhibit 242: SWOT
Exhibit 243: Cipla Inc. - Overview
Exhibit 244: Cipla Inc. - Business segments
Exhibit 245: Cipla Inc. - Key news
Exhibit 246: Cipla Inc. - Key offerings
Exhibit 247: Cipla Inc. - Segment focus
Exhibit 248: SWOT
Exhibit 249: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 250: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 251: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 252: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 253: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 254: SWOT
Exhibit 255: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 256: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 257: Glenmark Pharmaceuticals Ltd. - Key news
Exhibit 258: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibit 259: SWOT
Exhibit 260: Jubilant Pharmova Ltd. - Overview
Exhibit 261: Jubilant Pharmova Ltd. - Business segments
Exhibit 262: Jubilant Pharmova Ltd. - Key offerings
Exhibit 263: Jubilant Pharmova Ltd. - Segment focus
Exhibit 264: SWOT
Exhibit 265: Lupin Ltd. - Overview
Exhibit 266: Lupin Ltd. - Business segments
Exhibit 267: Lupin Ltd. - Key news
Exhibit 268: Lupin Ltd. - Key offerings
Exhibit 269: Lupin Ltd. - Segment focus
Exhibit 270: SWOT
Exhibit 271: Merck KGaA - Overview
Exhibit 272: Merck KGaA - Business segments
Exhibit 273: Merck KGaA - Key news
Exhibit 274: Merck KGaA - Key offerings
Exhibit 275: Merck KGaA - Segment focus
Exhibit 276: SWOT
Exhibit 277: Morepen Laboratories Ltd. - Overview
Exhibit 278: Morepen Laboratories Ltd. - Business segments
Exhibit 279: Morepen Laboratories Ltd. - Key offerings
Exhibit 280: Morepen Laboratories Ltd. - Segment focus
Exhibit 281: SWOT
Exhibit 282: Sun Pharmaceutical Industries - Overview
Exhibit 283: Sun Pharmaceutical Industries - Business segments
Exhibit 284: Sun Pharmaceutical Industries - Key news
Exhibit 285: Sun Pharmaceutical Industries - Key offerings
Exhibit 286: Sun Pharmaceutical Industries - Segment focus
Exhibit 287: SWOT
Exhibit 288: Teva Pharmaceutical Ltd. - Overview
Exhibit 289: Teva Pharmaceutical Ltd. - Business segments
Exhibit 290: Teva Pharmaceutical Ltd. - Key news
Exhibit 291: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 292: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 293: SWOT
Exhibit 294: Torrent Pharmaceuticals Ltd. - Overview
Exhibit 295: Torrent Pharmaceuticals Ltd. - Product / Service
Exhibit 296: Torrent Pharmaceuticals Ltd. - Key offerings
Exhibit 297: SWOT
Exhibit 298: Viatris Inc. - Overview
Exhibit 299: Viatris Inc. - Business segments
Exhibit 300: Viatris Inc. - Key news
Exhibit 301: Viatris Inc. - Key offerings
Exhibit 302: Viatris Inc. - Segment focus
Exhibit 303: SWOT
Exhibit 304: Inclusions checklist
Exhibit 305: Exclusions checklist
Exhibit 306: Currency conversion rates for US$
Exhibit 307: Research methodology
Exhibit 308: Information sources
Exhibit 309: Data validation
Exhibit 310: Validation techniques employed for market sizing
Exhibit 311: Data synthesis
Exhibit 312: 360 degree market analysis
Exhibit 313: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global global montelukast sodium market: Aarti Pharmalabs Ltd., Amneal Pharmaceuticals Inc., Apotex Inc., Aurobindo Pharma Ltd., Cipla Inc., Dr. Reddys Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Hetero Labs Ltd., Inke S.A., Jubilant Pharmova Ltd., Lupin Ltd., Macleods Pharmaceuticals Ltd., Merck KGaA, Metrochem API Pvt. Ltd., Morepen Laboratories Ltd., Sun Pharmaceutical Industries, Teva Pharmaceutical Ltd., Torrent Pharmaceuticals Ltd., Viatris Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is innovations in drug delivery systems and rise of fixed dose combination therapies."

According to the report, one of the major drivers for this market is the escalating prevalence of chronic respiratory diseases and allergic rhinitis increasing market demand.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Aarti Pharmalabs Ltd.
  • Amneal Pharmaceuticals Inc.
  • Apotex Inc.
  • Aurobindo Pharma Ltd.
  • Cipla Inc.
  • Dr. Reddys Laboratories Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Hetero Labs Ltd.
  • Inke S.A.
  • Jubilant Pharmova Ltd.
  • Lupin Ltd.
  • Macleods Pharmaceuticals Ltd.
  • Merck KGaA
  • Metrochem API Pvt. Ltd.
  • Morepen Laboratories Ltd.
  • Sun Pharmaceutical Industries
  • Teva Pharmaceutical Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Viatris Inc.